Drug traffic in the hepatobiliary system

Journal of Hepatology, Supplement

Volumn 24, Issue 1, 1996, Pages 3-28

  Groothuis, G M M ^a   Meijer, D K F ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Biliary excretion of drugs; Carrier mediated transport in liver; Cytosolic binding proteins; Hepatic uptake of drugs; Hepatobiliary transport; Hepatocyte heterogeneity in transport function; Intracellular distribution of drug; Lysosomal and mitochondrial storage; P glycoprotein mediated transport; Sinusoidal efflux of drugs

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ADIPIODONE; ANION; CATION; CHLORPROMAZINE; CYTOSOL RECEPTOR; DRUG; ETACRYNIC ACID; ETHIDIUM; FATTY ACID; GLYCOPROTEIN P; IMIPRAMINE; INDOCYANINE GREEN; LUCIGENIN; PROCAINAMIDE; PROPIDIUM IODIDE; PROPRANOLOL; QUINIDINE; RHODAMINE B; ROSE BENGAL; TAUROCHOLIC ACID; TETRAETHYLAMINE; TRIBUTYLMETHYLAMMONIUM; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG; VALINOMYCIN; VECURONIUM; VERAPAMIL;

AUTORADIOGRAPHY; BILIARY EXCRETION; CONFERENCE PAPER; DRUG TRANSPORT; HEPATOBILIARY SYSTEM; HUMAN; LIVER SINUSOID; LYSOSOME; MITOCHONDRION; PRIORITY JOURNAL;

ANIMALS; BILIARY TRACT; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; HUMANS; LIVER; PHARMACOKINETICS; TISSUE DISTRIBUTION;

EID: 0029990308     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (252)

1. Meijer DKF, Groothuis GMM. Hepatic transport of drugs and proteins. In: Mclntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology, Vol. 1. Oxford: Oxford University Press, 1991: 40-78.
2. Meijer DKF. Transport and metabolism in the hepatobiliary system. In: Schultz SG, Forte JG, Rauner BB, eds. Handbook of Physiology, Sect. 6, Vol. III. New York: Oxford University Press, 1989: 717-58.
3. Germann UA, Pastan I, Gottesman MM. P-glycoproteins: mediators of multi-drug resistance. Semin Cell Biol 1993; 4: 63-76.
4. Doige ÇA, Ames GFL. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multi-drug resistance. Annu Rev Microbiol 1993; 47: 291-319.
5. Meijer DKF, Mol WEM, Müller M, Kurz G. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations. J Pharmacokinet Biopharm 1990; 18: 35-70.
6. Groothuis GMM, Meijer DKF. Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs. Enzyme 1992; 46: 94-138.
7. Meijer DKF, Nijssen HMJ. Transport of drugs, proteins and drug-protein conjugates. In: Ballet F, Thurman RG, eds. Perfused Liver: Clinical and Basic Applications. London: John Libbey, 1991: 165-208.
8. Blom A, Scaf AHJ, Meijer DKF. Hepatic drug transport in the rat. A comparison between isolated hepatocytes, the isolated perfused liver and the liver in vivo. Biochem Pharmacol 1982; 31: 1553-65.
9. Gores GJ, Kost LJ, Larusso NF. The isolated perfused rat liver: conceptual and practical considerations. Hepatology 1986; 6: 511-7.
10. WolkofT AW, Johansen KL, GoeserT. The isolated perfused rat liver: preparation and application. Anal Biochem 1987; 167: 1-14.
11. Nijssen HMJ, Pijning T, Meijer DKF, Groothuis GMM. Influence of albumin on the net sinusoidal efflux of the organic anion dibromosulfophthalein from rat liver. Hepatology 1992; 15: 302-9.
12. Meijer DKF, Keulemans K, Mulder GJ. Isolated perfused rat liver technique. Methods Enzymol 1981; 77: 81-94.
13. Reichen J. Use of the perfused liver in studies of bile secretion. In: Ballet F, Thurman RG, eds. Research in Perfused Liver. London: John Libbey, 1991: 149-63.
14. Pang KS, Goresky CA, Schwab AJ. Deterministic factors underlying drug and metabolite clearances in rat liver perfusion studies. In: Ballet F, Thurman RG, eds. Research in Perfused Liver. London: John Libbey, 1991: 259-302.
15. Meijer DKF, Vonk RJ, Keulemans K, Weitering JG. Hepatic uptake and biliary excretion of dibromosulphthalein, albumin dependence, influence of phénobarbital and nafenopin pretreatment and the role of Y- and Z-protein. J Pharmacol Exp Ther 1977; 202: 8-21.
16. Proost JH, Nijssen HMJ, Strating CB, Meijer DKF, Groothuis GMM. Pharmacokinetic modeling of the sinusoidal efflux of anionic ligands from the isolated perfused rat liver: The influence of albumin. J Pharmacokinet Biopharm 1993; 21: 375-94.
17. Pang KS, Lee W-F, Cherry WF, Yuen V, Accaputo J, Schab AJ, Goresky CA. Effects of perfusate flow rate on measured blood volume, Disse space, intracellular water space and drug extraction in the perfused rat liver preparation: characterization by the multiple indicator dilution technique. J Pharmacokinet Biopharm 1988; 16: 595-632.
18. Nijssen HMJ, Pijning T, Meijer DKF, Groothuis GMM. Mechanistic aspects of uptake and sinusoidal efflux of dibromosulfophthalein in the isolated perfused rat liver. Biochem Pharmacol 1991; 42: 1997-2002.
19. Groothuis GMM, Hardonk MJ, Keulemans KTP, Nieuwenhuis P, Meijer DKF. Autoradiographic and kinetic demonstration of acinar heterogeneity of taurocholate transport. Am J Physiol 1982; 243: G455-62.
20. Groothuis GMM, Hardonk MJ, Meijer DKF. Hepatobiliary transport of drugs: do periportal and perivenous hepatocytes perform the same job? Trends Pharmacol Sei 1985; 6: 322-7.
21. Jones AL, Hradek GT, Renston RH, Wong KY, Karlaganis G, Paumgartner G. Autoradiographic evidence for hepatic lobular concentration gradient of bile acid derivative. Am J Physiol 1980; 238: G233-7.
22. Van der Sluijs P, Braakman I, Meijer DKF, Groothuis GMM. Heterogeneous acinar localization of the asialoglycoprotein internalization system in rat hepatocytes. Hepatology 1988; 8: 1521-9.
23. Braakman I, Groothuis GMM, Meijer DKF. Acinar redistribution and heterogeneity in transport of the organic cation rhodamine B in rat liver. Hepatology 1987; 7: 849-55.
24. Braakman I, Pijning T, Verest O, Weert B, Meijer DKF, Groothuis GMM. Vesicular uptake system for the cation lucigenin in the rat hepatocyte. Mol Pharmacol 1989; 36: 537-2.
25. Groothuis GMM, Weitering JG, Hardonk MJ, Meijer DKF. Heterogeneity of rat hepatocytes in transport and hepatic binding of asialo-alkaline phosphatase studied after induction of selective acinar damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride. Biochem Pharmacol 1983; 32: 2721-7.
26. Krumdieck CL, Dos Santon JE, Ho K-J. A new instrument for the rapid preparation of tissue slices. Anal Biochem 1980; 104: 118-23.
27. Connors S, Ramlin D, R., Gandolfi AJ, Krumdieck CL, Koep LJ, Brendel K. Cocaine hepatotoxicity in cultured liver slices: a species comparison. Toxicology 1990; 61: 17183.
28. Dogterom P, Rothuizen J. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs: qualitative and quantitative sex differences. Drug Metab Dispos 1993; 21: 705-9.
29. Fisher R, Putnam CVV, Koep LJ, Sipes IG, Gandolfi AJ, Brendel K. Cryopreservation of pig and human liver slices. Cryobiology 1991; 28: 1312.
30. Wishnies SM, Parrish AR, Sipes IG, Gandolfi AJ, Putnam CW, Krumdieck CL, Brendel K. Biotransformation activity in vitrified human liver slices. Cryobiology 1991; 28: 21626.
31. Olinga P, Merema MT, Meijer DKF, Slooff MJH, Groothuis GMM. Human liver sices express the same lidocaine biotransformation rate as isolated human hepatocytes. ATLA-AItern Lab Anim 1993; 21: 466-8.
32. Powis G. The use of human liver for foreign compound metabolism and toxicity studies. Drug Metab Rev 1989; 20: 379-94.
33. Schwenk M. Transport systems of isolated hepatocytes. Arch Toxicol 1980; 44: 113-26.
34. Berry MN, Halls HJ, Grivell MB. Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions. Life Sei 1992; 51: 1-16.
35. Miyauchi S, Sawada Y, Iga T, Hanano M, Sugiyama-Y. Comparison of the hepatic uptake clearances of 15 drugs with a wide range of membrane permeabilities in isolated rat hepatocytes and perfused rat livers. Pharm Res 1993; 10: 434-40.
36. Mol WEM, Fokkema GN, Weert B, Meijer DKF. Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes. J Pharmacol Exp Ther 1988; 244: 268-75.
37. Berry MN, Edwards AM, Barritt GJ. Utilization of hepatocytes for drug studies. In: Burdon RH, van Knippenberg PH, eds. Isolated hepatocytes preparation, properties and applications. Amsterdam: Elsevier, 1991: 182-4.
38. Wolkoff AW, Samuelson AC, Johansen KL, Nakata R, Withers DM, Sosiak A. Influence of Cl~ on organic anion transport in short-term cultured rat hepatocytes and isolated perfused rat liver. J Clin Invest 1987; 79: 1259-68.
39. Groothuis GMM, Hulstaert CE, Kalicharan D, Hardonk MJ. Plasma membrane specialization and intracellular polarity of freshly isolated rat hepatocytes. Eur J Cell Biol 1981;26:43-51.
40. Gebhardt R. Use of isolated and cultured hepatocytes in studies on bile formation. In: Guillouzo A, Guguen-Guillouzo C, eds. Research in Isolated and Cultured Hepatocytes. London: John Libbey Eurotext Ltd./INSERM, 1986: 353-76.
41. Oude Elferink RPJ, Ottenhoff R, Liefting WGM, Schoenmaker B, Groen AK, Jansen PLM. ATP-dependent efflux of GSSG and GS-conjugate from isolated rat hepatocytes. Am J Physiol 1990; 258: G699-706.
42. Tarao K, Clinger EJ, Ostrow D, Balistreri WF. Impaired bile acid efflux from hepatocytes isolated from liver of rats with cholestasis. Am J Physiol 1982; 243: G253-8.
43. Kwekkeboom J, Princen HMG, Van Voorthuizen EM, Meijer P, Kempen HJM. Comparison of taurocholate accumulation in cultured hepatocytes of pig, rat and man. Biochem Biophys Res Commun 1989; 162: 619-25.
44. Petzinger E, Frimmer M. Comparative investigations on the uptake of phallotoxins, bile acids, bovine lactoperoxidase and horseradish peroxidase into rat hepatocytes in suspension and in cell cultures. Biochim Biophys Acta 1988; 937: 1354.
45. Liang D, Hagenbuch B, Stieger B, Meier PJ. Parallel decrease of Na+-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes. Hepatology 1993; 18: 1163-6.
46. Föllmann W, Petzinger E, Kinne RKH. Alterations of bile acid and bumetanide uptake during culturing of rat hepatocytes. Am J Physiol 1990; 258: C700-12.
47. Sandker GW, Slooff MJH, Groothuis GMM. Drug transport, viability and morphology of isolated rat hepatocytes preserved for 24 hours in University of Wisconsin solution. Biochem Pharmacol 1992; 43: 1479-85.
48. Sandker GW, Weert B, Merema MT, Kuipers W, Slooff MJH, Meijer DKF, Groothuis GMM. Maintenance of viability and transport function after preservation of isolated rat hepatocytes in various simplified University of Wisconsin solutions. Biochem Pharmacol 1993; 46: 2093-6.
49. Chesné C, Guyomard C, Grislain L, Clerc C, Fautrel A, Guillouzo A. Use of cryopreserved animal and human hepatocytes for cytotoxicity studies. Toxicol in vitro 1991; 5: 479-82.
50. Quistorff B, Grunnet N. Dual-digitonin-pulse perfusion. Concurrent sampling of periportal and perivenous cytosol of rat liver for determination of metabolites and enzyme activities.Biochem J 1985; 229: 221-6.
51. Lindros KO, Penttilä KE. Digitonin-collagenase perfusion for efficient separation of periportal or perivenous hepatocytes. Biochem J 1985; 228: 757-60.
52. Braakman I, Keij J, Hardonk MJ, Meijer DKF, Groothuis GMM. Separation of periportal and perivenous rat hepatocytes by fluorescence-activated cell sorting: confirmation with colloidal gold as an exogenous marker. Hepatology 1991; 13: 73-82.
53. Buscher HP, Fricker G, Gerok W, Kurz G, Müller M, Schneider S, Schramm U, Schreyer A. Hepatic transport Systems for bile salts: localization and specificity. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile Acids and the Liver. Lancaster: MTP Press, 1987: 95-110.
54. Verkade HJ, Zaal KJ, Derksen JT, Vonk RJ, Hoekstra D, Kuipers F, Scherphof GL. Processing of the phospholipid analogue phosphatidyl (N-sulphorhodamine B sulphonyl) ethanolamine by rat hepatocytes in vitro and in riro. Biochem J 1992; 284: 259-65.
55. Fentem JH, Foster B, Mills CO, Coleman R, Chipman JK. Biliary excretion of fluorescent cholephiles in hepatocyte couplets: an in vitro model for hepatobiliary and hepatotoxicity studies. Toxicol in vitro 1990; 4: 452-7.
56. Nathanson MH, Burgstahler AD. Subcellular distribution of cytosolic Ca2+ in isolated rat hepatocyte couplets: evaluation using confocal microscopy. Cell Calcium 1992; 13: 8998.
57. Graf J, Boyer JL. The use of isolated rat hepatocyte coup-lets in hepatobiliary physiology. J Hepatol 1990; 10: 387-94.
58. Watanabe N, Tsukada N, Smith CR, Phillips MJ. Motility of bile canaliculi in the living animal: implications for bile flow. J Cell Biol 1991; 113: 1069-80.
59. Bayer JL, Philips JM, Graf J. Preparation and specific applications of isolated hepatocyte couplets. Methods Enzymol 1990; 192: 501-16.
60. Wilton JC, Williams DE, Strain AJ, Parslow RA, Chipman JK, Coleman R. Purification of hepatocyte couplets by centrifugal elutriation. Hepatology 1991; 14: 180-3.
61. Rogiers V. Cultures of human hepatocytes in in vitro pharmaco-toxicology. In: Rogiers V, Sonck W, Shephard E, Vercruysse A, eds. Human cells in in vitro pharmaco-toxicology. Brussels: VUB Press, 1992: 77-115.
62. Groothuis GMM, Sandker GW, Pruim J, Weert B, Slooff MJH, Meijer DKF. Comparison of human hepatocytes isolated from livers accepted or discarded for orthotopic transplantation. Toxicol in vitro 1995: 9: 951-8.
63. Sandker GW, Vos RME, Delbressine LPC, Slooff MJH, Meijer DKF, Groothuis GMM. Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo. Xenobiotica 1994; 24: 143-55.
64. Sandker GW, Weert B, Olinga P, Wolters H, Slooff MJH, Meijer DKF, Groothuis GMM. Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. Biochem Pharmacol 1994; 47: 2193-200.
65. Azer SA, Stacey NH. Differential effects of cyclosporin-A on the transport of bile acids by human hepatocytes. Biochem Pharmacol 1993; 46: 813-9.
66. Blitzer BL, Donovan CB. A new method for the rapid isolation of basolateral plasma membrane vesicles from rat liver, characterization, validation and bile acid transport studies. J Biol Chem 1984; 259: 9295-301.
67. Meier PJ, Meier-Abt AS, Barren C, Boyer JL. Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier. J Biol Chem 1984; 259: 10614-22.
68. Hardikar W, Suchy FJ. A new bile acid transporter? Hepatology 1993; 18: 1278-9.
69. Adachi Y, Kobayashi H, Kurumi Y, Shouji M, Kitano M, Yamamoto T. ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 1991; 14: 655-9.
70. Novak DA, Ryckman FC, Suchy FJ. Taurocholate transport by basolateral plasma membrane vesicles isolated from human liver. Hepatology 1989; 10: 447-53.
71. Wolters H, Kuipers F, Slooff MJH, Vonk RJ. Adenosine triphosphate-dependent taurocholate transport in human liver plasma membranes. J Clin Invest 1992; 90: 2321-6.
72. Von Dippe P, Ananthanarayanan M, Drain P, Levy D. Purification and reconstitution of the bile acid transport system from hepatocyte sinusoidal plasma membranes. Biochim Biophys Acta 1986; 862: 352-60.
73. Stremmel W, Gerber M, Glezerov V, Thung SN, Kochwa S, Berk PD. Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes. J Clin Invest 1983; 71: 1796-805.
74. Reichen J, Berk PD. Isolation of an organic anion binding protein from rat liver plasma membrane fractions by affinity chromatography. Biochem Biophys Res Commun 1979; 91: 484-9.
75. Wolkoff AW, Chung CT. Identification, purification and partial characterization of an organic anion binding protein from rat liver cell plasma membrane. J Clin Invest 1980; 65: 1152-61.
76. Mol WEM, Müller M, Kurz G, Meijer DKF. Investigations on the hepatic uptake systems for organic cations with a photoaffinity probe of procainamide ethobromide. Biochem Pharmacol 1992; 43: 2217-26.
77. Mol WEM, Müller M, Meijer DKF. Synthesis of 4-azidoN-[2-(diethylmethylammonium)ethyl]benzamide iodide: a photolabile derivative of procainamidethobromide. Arch Pharm 1989; 322: 613-5.
78. Müller M, Mol WEM, Meijer DKF, Kurz G. Hepatic transport systems for bulky organic cations. Kinetic and photoaffinity labeling studies to characterize potential carrier proteins for uptake of amphipathic (type 2) cations. Submitted 1995.
79. Hagenbuch B, Stieger B, Foguet M, Lübbert H, Meier PJ. Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. Proc Natl Acad Sei USA 1991; 88: 10629-33.
80. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ. Expression of the hepatocellular chloride-dependent sulfobromophthalein uptake system in Xenopiis laevis oocytes. J Clin Invest 1991; 88: 2146-9.
81. Xie M-H, Cochran M, Lidofsky SD, Scharschmidt BF. A 1.8-3 kb mRNA encodes for a hepatic organic cation transport protein. Hepatology 1992; 16: 147A.
82. Shneider BL, Moyer MS. Characterization of endogenous carrier-mediated taurocholate efflux from Xenopiis laevis oocytes. J Biol Chem 1993; 268: 6985-8.
83. George CF. Drug kinetics and hepatic blood flow. Clin Pharmacokinet 1979; 4: 4338.
84. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987; 39: 1-47.
85. Meijer DKF, Van der Sluijs P. Covalent and noncovalent protein binding of drugs: Implications for hepatic clearance, storage, and cell-specific drug delivery. Pharm Res 1989; 6: 105-18.
86. Buscher HP, Schramm K, MacKelly S, Kurz G, Gerok W. The acinar location of the sodium-independent and the sodium-dependent component of taurocholate uptake. A histoautoradiographic study of rat liver. J Hepatol 1991; 13: 169-79.
87. Berk PD, Potter BJ, Stremmel W. Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology 1987; 7: 16576.
88. Meijer DKF, Blom A, Weitering JG, Hornsveld R. Pharmacokinetics of the hepatic transport of organic anions: Influence of extra- and intracellular binding on hepatic storage of dibromosulfophthalein and interactions with indocyanine green. J Pharmacokinet Biopharm 1984; 12: 43-65.
89. Van der Sluijs P, Spanjer HH, Meijer DKF. Hepatic disposition of cationic drugs bound to asialo-orosomucoid: lack of co-endocytosis and evidence for intrahepatic dissociation. J Pharmacol Exp Ther 1987; 240: 668-73.
90. Van der Sluijs P, Meijer DKF. Binding of drugs with a quaternary ammonium group to alpha-1 acid glycoprotein and asialo alpha-1 acid glycoprotein. J Pharmacol Exp Ther 1985; 234: 703-7.
91. Goresky CA. The lobular design of the liver: its effect on uptake processes. In: Lundgvist F, Tygstrup N, eds. Regulation of Hepatic Metabolism. Copenhagen: Munksgaard, 1974: 808-22.
92. Goresky CA, Schwab AJ. Flow, Cell entry and metabolic disposal: their interactions in hepatic uptake. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. New York: Raven Press, 1988:807-31.
93. Weisiger RA. Dissociation from albumin: a potentially ratelimiting step in the clearance of substances by the liver. Proc Natl A~cad Sei USA 1985; 82: 1563-7.
94. Bass L, Keiding S. Physiologically based models and strategic experiments in hepatic pharmacology. Biochem Pharmacol 1988; 37: 1425-31.
95. Forker EL, Luxon BA. Albumin helps mediate removal of taurocholate by rat liver. J Clin Invest 1981; 67: 1517-22.
96. Van der Sluijs P, Postema B, Meijer DKF. Lactosylation of albumin reduces uptake rate of dibromosulfophthalein in perfused rat liver and dissociation rate from albumin in vitro. Hepatology 1987; 7: 688-95.
97. Gumucio DL, Gumucio JJ, Wilson JAP, Cutter C, Krauss M, Caldwell R, Chen E. Albumin influences sulfobromophthalein transport by hepatocytes of each acinar zone. Am J Physiol 1984; 246: G86-95.
98. Groothuis GMM, Keulemans KTP, Hardonk MJ, Meijer DKF. Acinar heterogeneity in hepatic transport of dibromosulfophthalein and ouabain studied by autoradiography, normal and retrograde perfusions and computer simulation. Biochem Pharmacol 1983; 32: 3069-78.
99. Steen H, Meijer DKF. Biliary excretion of endogenous and exogenous compounds: Organic cations. In: Siegers CP, Watkins III JB, eds. Biliary excrétion of drugs and other chemicals. Stuttgart: Gustav Fischer, 1991: 239-72.
100. Meier PJ. Transport polarity of hepatocytes. Semin Liver Dis 1988; 8: 293-307.
101. Frimmer M. Organotropism by carrier-mediated transport. Trends Pharmacol Sei 1982; 3: 395-7.
102. Stremmel W, Strohmeyer G, Berk PD. Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sei USA 1986; 83: 3584-8.
103. Ziegler K. Identification of carrier proteins in hepatocytes by (photo)affinity labels derived from foreign cyclopeptides. In: Petzinger E, Kinne RKH, Sies H, eds. Hepatic transport of organic substances. Berlin: Springer, 1989: 317-26.
104. Zimmerli B, Valantinas J, Meier PJ. Multispecificity of Na+dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles. J Pharmacol Exp Ther 1989; 250: 301-8.
105. Chung YB, Miyauchi S, Sugiyama Y, Harashima H, Iga T, Hanano M. Effect of various organic anions on the plasma disappearance of l-anilino-8-naphthalene sulfonate. J Hepatol 1990; 11:240-51.
106. Minder E, Paumgartner G. Disparate Na+-requirement of taurocholate and indocyanine green uptake by isolated hepatocytes. Experientia 1979; 35: 888-90.
107. Sottocasa GL, Baldini G, Passamonti S, Lunazzi GC. Electrogenic sulfobromophthalein (BSP) movements mediated by bilitranslocase in liver plasma membrane vesicles. J Hepatol 1985; I: S133.
108. Pctzinger E. Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport. Rev Physiol Biochem Pharmacol 1994; 123: 47-211.
109. Hagenbuch B, Lübbert H, Stieger B, Meier PJ. Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laeris oocytes. J Biol Chem 1990; 265: 5357-60.
110. Petzinger E, Fischer K, Fasold H. Role of the bile acid transport system in hepatocellular ouabain uptake. In: Erdmann E, Grieff K, Akou JC, eds. Cardiac Glycosides 17851985. Biochemistry, Pharmcology, Clinical Relevance. Darmstadt: Steinkopf, 1986: 297-304.
111. Levy D, Von Dippe P, Amoui M, Stolz A, Stellwagen R, Alves C. The sodium-dependent bile acid transporter is a bifunctional protein that expresses carcinogen expoxide hydrolase activity. Hepatology 1991; 14: 136A.
112. Sottocasa GL, Lunazzi GC, Tiribelli C. Isolation of bilitranslocase, the anion transporter from liver plasma membrane for bilirubin and other organic anions. Methods Enzymol 1989; 174: 50-7.
113. Sottocasa GL, Baldini G, Sandri G, Lunazzi G, Tiribelli C. Reconstitutions in vitro of sulfobromophthalein transport by bilitranslocase. Biochim Biophys Acta 1982; 685: 123-8.
114. Torres AM, Lunazzi GL, Stremmel W, Rodilla-Sala E, Tiribelli C. Two distinct proteins account for the hepatic uptake of organic anions: kinetic and immunological evidence. Hepatology 1992; 16: 145A.
115. Meijer DKF, Ziegler K. Mechanisms for the hepatic clearance of oligopeptides and proteins. Implications for rate of elimination, bioavailability and cell-specific drug delivery to the liver. In: Audus KL, Raub TJ, eds. Biological Barriers to Protein Delivery. New York: Plenum Press, 1993: 339408.
116. Hunter EB, Powers SP, Kost LJ, Pinon DI, Miller LJ, Larusso NF. Physicochemical determinants in hepatic extraction of small peptides. Hepatology 1990; 12: 76-82.
117. Mol WEM, Rombout F, Paanakker JE, Costing R, Scaf AHJ, Meijer DKF. Pharmacokinetics of steroidal muscle relaxants in isolated perfused rat liver. Biochem Pharmacol 1992; 44: 1453-9.
118. Brass EP. Carnitine transport. In: Ferrari R, DiMauro S, Sherwood G, eds. L-Carnitine and Its Role in Medicine: From Function To Therapy. London: Academic Press; Harcourt Brace Jovanovich, 1992: 21-36.
119. Liscovitch M, Lavie Y. Sphingoid bases as endogenous cationic amphiphilic "drugs". Biochem Pharmacol 1991; 42: 2071-5.
120. Byers TL, Bitonti AJ, Mccann PP. Bis(benzyl)polyamine analogues are substrates for a mammalian cell-transport system which is distinct from the polyamine-transport system. Biochem J 1990; 269: 350.
121. Khan NA, Quemener V, Moulinoux JP. Polyamine membrane transport regulation. Cell Biol Int Rep 1991; 15: 924.
122. Toninello A, Dalla Via L, Siliprandi D, Garlid KD. Evidence that spermine, spermidine, and putrescine are transported electrophoretically in mitochondria by a specific polyamine uniporter. J Biol Chem 1992; 267: 18393-7.
123. Steen H, Meijer DKF. Organic cations. Prog Pharmacol Clin Pharmacol 1991; 8/4: 239-72.
124. Agoston S, Vermeer GA, Ketten UW, Meijer DKF. The fate of pancuronium bromide in man. Acta Anaesthesiol Scand 1973; 17: 267-75.
125. Meijer DKF, Vermeer GA, Kwant G. The excretion ofhexafluorenium in man and rat. Eur J Pharmacol 1971; 14: 2805.
126. Meijer DKF, Weitering JG, Vermeer GA, Scaf AHJ. Comparative pharmacokinetics of d-tubocurarine and metocurine in man. Anesthesiology 1979; 51: 402-7.
127. Steen H, Costing R, Meijer DKF. Mechanisms for the uptake of cationic drugs by the liver: A study with tributylmethylammonium (TBuMA). J Pharmacol Exp Ther 1991; 258: 537-43.
128. Steen H, Merema M, Meijer DKF. A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liver. Biochem Pharmacol 1992; 44: 2323-31.
129. Moseley RH, Morrissette J, Johnson TR. Transport of N1methylnicotinamide by organic cation-proton exchange in rat liver membrane vesicles. Am J Physiol 1990; 259: G97382.
130. Moseley RH, Jarose SM, Permoad P. Organic cation transport by rat liver plasma membrane vesicles: studies with tetraethylammonium. Am J Physiol 1992; 263: G775-85.
131. McKinney TD, Hosford MA. Organic cation transport by rat hepatocyte basolateral membrane vesicles. Am J Physiol 1992; 263: G939-46.
132. Moseley RH, Vashi PG, Jarose SM, Dickinson CJ, Permoad PA. Thiamine transport by basolateral rat liver plasma membrane vesicles. Gastroenterology 1992; 103: 1056-65.
133. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-52.
134. Braakman I, Groothuis GMM, Meijer DKF. Zonal compartmentation of perfused rat liver: plasma reappearance of rhodamine B explained. J Pharmacol Exp Ther 1989; 249: 869-73.
135. Braakman I: Hepatocyte heterogeneity in organic cation transport. Rijksuniversiteit Groningen, Thesis, 1988.
136. Braakman I, Verest O, Pijning T, Meijer DKF, Groothuis GMM. Zonal distribution of the cation lucigenin in rat liver: influence of taurocholate. Mol Pharmacol 1990; 36: 532-6.
137. Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol 1991; 10: 100-6.
138. Steen H, Maring JG, Meijer DKF. Differential effects of metabolic inhibitors on cellular and mitochondrial uptake of organic cations in rat liver. Biochem Pharmacol 1993; 45: 809-18.
139. King PD, Cai Z-S. Uptake of tributylmethylammonium into rat liver basolateral plasma membrane vesicles is mediated by proton exchange. Gastroenterology 1993; 104: A927.
140. Buscher HP, Mittenberger C, MacNelly S, Gerok W. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes. J Hepatol 1989; 8: 181-91.
141. Buscher H-P, Meder I, MacNelly S, Gerok W. Zonal changes of hepatobiliary taurocholate transport in intrahepatic cholestasis induced by 17cr-ethinyl estradiol: a histoautoradiographic study in rats. Hepatology 1993; 17: 494-9.
142. Gumucio JJ, Miller DL, Krauss MD, Cutter Zanolli C. Transport of fluorescent compounds into hepatocytes and the resultant zonal labeling of the hepatic acinus in the rat. Gastroenterology 1981; 80: 639-16.
143. Thalhammer T, Fellingcr A, Meijer DKF, Groothuis GMM, Graf J. Separation of periportal and centrilobular rat liver parenchym cells in a fluorescence activated cell sorter after acridine orange staining. In: Davison JS, Shaffer EA, eds. Gastrointestinal and Hepatic Secretions: Mechanisms and Control. New York: The University of Calgary Press, 1988: 82-4.
144. Anderson JH, Anderson RC, Iben LS. Hepatic uptake of propranolol. J Pharmacol Exp Ther 1978; 206: 172-80.
145. Fujii T, Miyazaki H, Nambu K, Furukawa H, Hashimoto M. Autoradiographic and biochemical studies of drug distribution in the liver. I. [HC]-Dehydrocorydaline. Eur J Drug Metab Pharmacokinet 1984; 9: 235-16.
146. Fujii T, Miyazaki H, Nambu K, Matsumoto K, Hashimoto M. Autoradiographic and biochemical studies of drug distribution in the liver. II. [35S]-chIorpromazine and [l4C]-imipramine. Eur J Drug Metab Pharmacokinet 1984; 9: 24755.
147. Fujii T, Miyazaki H, Hashimoto M. Autoradiographic and biochemical studies of drug distribution in the liver. III. [14C]-Aminotriazole. Eur J Drug Metab Pharmacokinet 1984; 9: 257-65.
148. Meijer DKF. The mechanisms for hepatic uptake and biliary excretion of organic cations. In: Kramer M, Lauterbach F, eds. Intestinal permeation. Amsterdam: Excerpta Medica, 1976: 196-207.
149. Mol WEM, Meijer DKF. Hepatic transport mechanisms for bivalent organic cations. Subcellular distribution and hepato-biliary concentration gradients of some steroidal muscle relaxants. Biochem Pharmacol 1990; 39: 383-90.
150. Capron F, Coltoff-Schiller B, Johnson AB, Fleischner GM, Goldfisher S. Immunohistochemical localization of hepatic ligandin and Z protein utilizing frozen sections for light and electron microscopy. J Histochem Cytochem 1979; 27: 9616.
151. Bass NM, Barker ME, Manning J, Jones AL, Ockner RK. Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats. Hepatology 1989; 9: 12-21.
152. Suzuki T, Ono T. Immunohistochemical studies on the distribution and frequency of fatty-acid-binding protein positive cells in human fetal, newborn and adult liver tissues. J Pathol 1987; 153: 385-94.
153. Sugiyama Y, Yamada T, Kaplowitz N. Newly identified bile acid binders in rat liver cytosol: purification and comparison with glutathione S-transferase. J Biol Chem 1983; 258: 3602-9.
154. Burr R, Schwenk M, Pfaff E. Interaction of bromosulfophthalein with mitochondrial membranes - inhibition of respiration. Biochem Pharmacol 1977; 26: 461-6.
155. Laperche Y, Oudea P. Inhibition by sulfobromophthalein of mitochondrial translocation of anions and adenine nucleotides: Effects upon liver adenosine triphosphate and possible correlation with inhibition of bile flow in the rat. J Pharmacol Exp Ther 1976; 197: 235-14.
156. Laperche Y, Oudea MC, Loatanlen D. Toxic effects of indocyanine green on rat liver mitochondria. Toxicol Appl Pharmacol 1977; 41: 377-87.
157. Gregus Z, Klaassen CD. Enterohepatic circulation of toxicants. In: Roxman K, Hänninen O, eds. Gastrointestinal Toxicology. Amsterdam: Elsevier Science Publishers, 1986: 57-118.
158. Meijer DKF, Wester J, Gunnik M. Distribution of quaternary ammonium compounds between particulate and soluble constituents of rat liver in relation to their transport from plasma into bile. Naunyn Schmiedebergs Arch Pharmacol 1972; 273: 179-92.
159. Weitering JG, Lammers W, Meijer DKF, Mulder GJ. Localization of d-tubocurarine in rat liver lysosomes. Lysosomal uptake, biliary excretion and displacement by quinacrine in vivo. Naunyn Schmiedebergs Arch Pharmacol 1977; 299; 277-81.
160. Meijer DKF, Weitering JG, Vonk RJ. Hepatic uptake and biliary excretion of d-tubocurarine and trimethylcurarine in the rat in vivo and in isolated perfused rat livers. J Pharmacol Exp Ther 1976; 198: 229-39.
161. Van Dyke RW, Faber ED, Meijer DKF. Sequestration of organic cations by acidified hepatic endocytic vesicles and implications for biliary excretion. J Pharmacol Exp Ther 1992; 261: 1-11.
162. Weitering JG, Mulder GJ, Meijer DKF, Lammers W, Veenhuis M, Wendelaar Bonga SE. On the localization of dtubocurarine in rat liver lysosomes in vivo by electron microscopy and subcellular fractionation. Naunyn Schmiedebergs Arch Pharmacol 1975; 289: 251-6.
163. Maclntyre AC, Cutler DJ. Role of lysosomes in hepatic accumulation of chloroquine. J Pharmacol Sei 1988; 77: 1969.
164. Ward SA. Mechanisms of chloroquine resistance in malarial chemotherapy. Trends Pharmacol Sei 1988; 9: 241-6.
165. Woolley GA, Kapral MK, Deber CM. Potential-sensitive membrane association of a fluorescent dye. FEBS Lett 1987; 224: 337-42.
166. Bunting JR, Phan TV, Kamali E, Dowben RM. Fluorescent cationic probes of mitochondria. Metrics and mechanism of interaction. Biophys J 1989; 56: 979-93.
167. Steen H. Mechanisms for the hepatic disposition of organic cations. Molecular aspects of membrane transport in the hepatocyte. Rijksuniversiteit Groningen, Thesis, 1992.
168. Krämer R, Mayr U, Heberger C, Tsompanidou S. Activation of the ADP/ATP carrier from mitochondria by cationic effectors. Biochim Biophys Acta 1986; 855: 201-10.
169. Porter RK, Scott JM, Brand MD. Choline transport into rat liver mitochondria. Characterization and kinetics of a specific transporter. J Biol Chem 1992; 267: 14637-46.
170. Müller M. Membrantransport von organischen Kationen in Hepatocyten. Ein Beitrag zur Aufklärung von hepatischen Transportvorgängen. Universität von Freiburg, Dissertation, 1988.
171. Buscher H-P, Fricker G, Gerok W, Kramer W, Kurz G, Müller M, Schneider S. Membrane transport of amphiphilic compounds by hepatocytes. In: Greten H, Windler E, Beisiegel U, eds. Receptor-Mediated Uptake in the Liver. Berlin: Springer, 1986: 189-99.
172. Diwan JJ, Yune HH, Bawa R, Haley T, Mannella CA. Enhanced uptake of spermidine and methylglyoxal-bis(guanylhydrazone) by rat liver mitochondria following outer membrane lysis. Biochem Pharmacol 1988; 37: 957-61.
173. Mannella ÇA, Wang Q. Permeability of the mitochondrial outer membrane to organic cations. Biochim Biophys Acta 1989; 981:363-6.
174. Koch JK, Gallagher CH. The effect of neuromuscular blocking agents on mitochondria. I. Effects of d-tubocurarine and of complex ions on mitochondrial enzyme systems. Biochem Pharmacol 1960; 3: 231-t3.
175. Zimmermann H W. Physicochemical and cytochemical investigations on the binding of ethidium and acridine dyes to DNA and to organelles in living cells. Angew Chem [Int Ed] 1986; 25: 115-30.
176. Yeh CG, Hsi B, Faulk \VP. Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies. J Immunol 1981; 43: 269-75.
177. Ronot X, Benel L, Adolphe M, Mounolou JC. Mitochondria! analysis in living cells: The use of rhodamine 123 and flow cytometry. Biol Cell 1986; 57: 1-8.
178. Traber PG, Chianale J, Gumucio JJ. Physiologic significance and regulation of hepatocellular heterogeneity. Gastroenterology 1988; 95: 1130-43.
179. Baumgartner U, Miyai K, Hardison WGM. Greater taurodeoxycholate biotransformation during backward perfusion of rat liver. Am J Physiol 1986; 251: 431-5.
180. Loud AV. A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J Cell Biol 1968; 37: 27-46.
181. Horie T, Mizuma T, Kasai S, Awazu S. Conformational change in plasma albumin due to interaction with isolated rat hepatocyte. Am J Physiol 1988; 254: G465-70.
182. Reed RG, Burrington CM. The albumin receptor effect may be due to a surface-induced conformational change in albumin. J Biol Chem 1989; 264: 9867-72.
183. Nijssen HMJ, Pijning T, Proost JH, Meijer DKF, Groothuis GMM. The sinusoidal efflux of dibromosulfophthalein from rat liver is stimulated by albumin, ligandin and fatty acid binding protein but not by other dibromosulfophthalein binding proteins. J Hepatol 1994; 21: 29-36.
184. Mizuma T, Komori M, Ueno M, Horikoshi I. Sulphate conjugation enhances reversible binding of drug to human serum albumin. J Pharm Pharmacol 1991; 43: 446-8.
185. Kobayashi K, Sogame Y, Hara H, Hayashi K. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J Biol Chem 1990; 265: 7737-11.
186. Fernandez-Checa JC, Ren C, Aw TY, Ookhtens M, Kaplowitz N. Effect of membrane potential and cellular ATP on gluthatione efflux from isolated rat hepatocytes. Am J Physiol 1988; 255: G403-8.
187. Wright TL, Fitz JG, Boyer TD. Hepatic efflux of glutathione by the perfused rat liver: role of membrane potential difference. Am J Physiol 1988; 255: G547-55.
188. Ookhtens M, Hobdy K, Corvasce MC, Aw TY, Kaplowitz N. Sinusoidal efflux of glutathione in the perfused rat liver. Evidence for a carrier-mediated process. J Clin Invest 1985; 75: 258-65.
189. Akerboom TPM, Sies H. Transport of glutathione, glutathione disulfide, and glutathione conjugates across hepatocyte plasma membrane. Methods Enzymol 1989; 173: 523-34.
190. De Vries MH, Groothuis GMM, Mulder GJ, Nguyen H, Meijer DKF. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism. Biochem Pharmacol 1985; 34: 2129-35.
191. Ookhtens M, Lyon I, Fernandez-Checa J, Kaplowitz N. Inhibition of glutathione efflux in the perfused rat liver and isolated hepatocytes by organic anions and bilirubin. Kinetics, sidedness and molecular forms. J Clin Invest 1988; 82: 608-16.
192. Nicotera P, Moore M, Bellamo G, Mirabelli F, Orrenius S. Demonstration and partial characterization of glutathione disulfide-stimulated ATPase activity in plasma membrane fraction of rat hepatocytes. J Biol Chem 1985; 260: 19992002.
193. Garcia-Ruiz C, Fernandez-Checa JC, Kaplowitz N. Membrane transport of GSH is bi-directional in intact hepatocytes. Hepatology 1991; 14: 154A.
194. Min AD, Johansen KL, Campbell CG, Wolkoff AW. Role of chloride and intracellular pH on the activity of the rat hepatocyte organic anion transporter. J Clin Invest 1991; 87: 1496-502.
195. Tiribelli C, Lunazzi GC, Sottocasa GL. Biochemical and molecular aspects of the hepatic uptake of organic anions. Biochim Biophys Acta 1990; 1031: 261-75.
196. Baumgartner U, Scholmerich J, Karsch J, Gerok W, Farthmann EH. Loss of zonal heterogeneity and cell polarity in rat liver with respect to bile acid secretion after bile drainage. Gastroenterology 1991; 100: 1054-61.
197. Weinman SA, Graf J, Boyer JL. Voltage-driven, taurocholate-dependent secretion in isolated hepatocyte couplets. Am J Physiol 1989; 256: G826-32.
198. Meier PJ, Meier-Abt AS, Boyer JL. Properties of the canalicular bile acid transport system in rat liver. Biochem J 1987; 242: 465-9.
199. Ruifrok PG. Uptake of quaternary ammonium compounds into rat liver plasma membrane vesicles. Biochem Pharmacol 1982; 31: 1431-5.
200. Scharschmidt BF, Schmid R. The micellar sink. A quantitative assessment of the association of organic anions with mixed micelles and other macromolecular aggregates in rat bile. J Clin Invest 1978; 62: 1122-31.
201. Müller M, Mayer R, Hero U, Keppler D. ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdrl P-gycoprotein. FEES Lett 1994; 343: 168-72.
202. Kobayashi K, Komatsu S, Nishi T, Hara H, Hayashi K. ATP-dependent transport for glucuronides in canalicular plasma membrane vesicles. Biochem Biophys Res Commun 1991; 176: 622-6.
203. Ishikawa T, Müller M, Klünemann C, Schaub T, Keppler D. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem 1990; 265: 19279-86.
204. Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of Gpl70, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 1989; 264: 11693-8.
205. Sinicrope FA, Dudeja PK, Bissonnette BM, Safa AR, Brasitus TA. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J Biol Chem 1992; 267: 24995-5002.
206. Müller M, Mayer R, Hero U, Keppler D. ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdrl P-glycoprotein. FEES Lett 1994; 343: 168-72.
207. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991; 14: 551-66.
208. Crawford JM, Hauser SC, Gollan JL. Formation, hepatic metabolism, and transport of bile pigments: a status report. Semin Liver Dis 1988; 8: 105-18.
209. Erlinger S. Role of intracellular organelles in the hepatic transport of bile acids. Biomed Pharmacother 1990; 44: 409-16.
210. Tokumo H, Mancuso DJ, Busch N, Holzbach RT. Hydrophobicity is an important mechanism in hepatic uptake of organic anions. Hepatology 1988; 8: 1265.
211. Oude Elferink RPJ, Ottenhoff R, Liefting W, De Haan J, Jansen PLM. Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia. J Clin Invest 1989; 84: 476-83.
212. Oude Elferink RPJ, De Haan J, Lambert KJ, Hagey LR, Hofmann AF, Jansen PLM. Sélective hepatobiliary transport of nordeoxycholate side chain conjugates in mutant rats with a canalicular transport defect. Hepatology 1989; 9: 861-5.
213. Jansen PLM, Groothuis GMM, Peters WHM, Meijer DKF. Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary-conjugated hyperbilirubinemia. Hepatology 1987; 7: 71-6.
214. Kuipers F, Radominska A, Zimniak P, Little JM, Havinga R, Vonk RJ, Lester R. Defective biliary secretion of bile acid 3-O-glucuronides in rats with hereditary conjugated hyperbilirubinemia. J Lipid Res 1989; 30: 1835-45.
215. Barnhart JL, Gronwall RR, Combes B. Biliary excretion of sulfobromophthalein compounds in normal and mutant corridale sheep. Evidence for disproportionate transport defect for conjugated sulfobromophthalein. Hepatology 1981; 1:441-7.
216. Javitt NB, Kondo T, Kuchiba K. Bile acid excretion in Dubin-Johnson syndrome [letter]. Gastroenterology 1978; 75: 931-2.
217. Stieger B, O'Neill B, Meier PJ. ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles. Biochem J 1992; 284: 67-74.
218. Nishida T, Gatmaitan Z, Che MX, Arias IM. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc Natl Acad Sei USA 1991; 88: 6590-4.
219. Anwer MS, Nolan K, Hardison WGM. Role of bicarbonate in biliary excretion of diisothiocyanostilbene disulfonate. Am J Physiol 1988; 255: G713-22.
220. Kuipers F, Enserink M, Havinga R, van der Steen ABM, Hardonk MJ, Fevery J, Vonk RJ. Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat. J Clin Invest 1988; 81: 1593-9.
221. Müller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, De Vries EGE, Jansen PLM. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione Sconjugate transport. Proc Natl Acad Sei USA 1994; 91: 13033-7.
222. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 1994; 54: 4833-6.
223. Smit JW, Steen H, Meijer DKF. Modulators of protein kinase C as well as MDR reversal agents have a major influence on the biliary excretion of the cationic drugs tri-N-butylmethyl-ammonium (TBuMA) and doxorubicin. In: Keppler D, Jungermann K, eds. Transport in the Liver. Hei-. delberg: Falk Symposium No. 74, 1994: Abstract-no. 27.
224. Speeg KV, Maldonado AL. Effect of cyclosporine on colchicine partitioning in the rat liver. Cancer Chemother Pharmacol 1993; 32: 434-6.
225. Speeg KV, Maldonado AL, Liaci J, Muirhead D. Effect of cyclosporine on colchicine secretion by a liver canalicular transporter studied in vivo. Hepatology 1992; 15: 899-903.
226. Thalhammer T, Stapf V, Gajdzik L, Graf J. Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport. Eur J Pharmacol 1994; 270: 213-20.
227. Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M, Sugiyama Y. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine. J Hepatol 1992; 16: 77-88.
228. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
229. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1988; 33: 454-62.
230. Buschman E, Arceci RJ, Croop JM, Che MX, Arias IM, Housman DE, Gros P. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J Biol Chem 1992; 267: 180939.
231. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrugresistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sei USA 1987; 84: 7735-8.
232. Bradley G, Georges E, Ling V. Sex dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster. J Cell Physiol 1990; 145: 398-108.
233. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sei USA 1987; 84: 265-9.
234. Schrenk D, Gant TW, Preisegger K-H, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17: 854-60.
235. Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J, Broxterman HJ. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 1993; 68: 939-46.
236. Grunicke H, Hofmann J. Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmacol Ther 1992; 55: 1-30.
237. Steen H, Smit H, Nijholt A, Merema M, Meijer DKF. Modulators of the protein kinase C system influence biliary excretion of cationic drugs. Hepatology 1993; 18: 1208-15.
238. Gosland M, Tsuboi C, Hoffman T, Goodin S, Vore M. 17/?Estradiol glucoronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Cancer Res 1993; 53: 5382-5.
239. Vore M. Canalicular transport: discovery of ATP-dependent mechanisms. Toxicol Appl Pharmacol 1993; 118: 2-7.
240. Arias IM. Is the multidrug resistance an ATP channel? Hepatology 1993; 18: 216-7.
241. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, Van Deemter L, Mol CAAM, Ottenhoff R, Van der Lugt NMT, van Roon MA, Van der Valk MA, Offerhaus GJA, Berns AJM, Borst P. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
242. Schinkel AH, Borst P. Multidrug resistance mediated by Pglycoproteins. Semin Cancer Biol 1991; 2: 213-26.
243. Reichen JKM. Expansion of the bile acid pool changes the biliary transport characteristics of centrizonal hepatocytes. Experientia 1989; 45: 135-7.
244. Baumgartner U, Miyai K, Hardison WGM. Modulation of hepatic biotransformation and biliary excretion of bile acid by age and sinusoidal bile acid load. Am J Physiol 1987; 252: Gl 14-9.
245. Baumgartner U, Sellinger M, Ruf G, Jehle L, Ihling C, Farthmann EH. Change of zonal bile acid processing after partial hepatectomy in the rat. J Hepatol 1995; 22: 474-80.
246. Simon FR, Sutherland EM, Gonzalez M. Regulation of bile salt transport in rat liver. Evidence that increased maximum bile salt secretory capacity is due to increased cholic acid receptors. J Clin Invest 1982; 70: 401-11.
247. Baumgartner U, Hardison WGM, Miyai K. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver. Lab Invest 1987; 56: 576-82.
248. Sherman IA, Fisher MM. Hepatic transport of fluorescent molecules: In vivo studies using intravital TV microscopy. Hepatology 1986; 6: 444-9.
249. Groothuis GMM, Boer Bd, Kuipers F, Meijer DKF. Heterogeneity of rat hepatocytes in metabolism and biliary transport of cholic acid and glycocholic acid. Hepatology 1988; 8: 1364 (Abstract).
250. Groothuis GMM, Weitering JG, Keulemans KTP, Hardonk MJ, Mulder D, Meijer DKF. Heterogeneity of rat hepatocytes in bile acid and DBSP transport studied after induction of selective acinar damage by N-hydroxy-2-acetylaminofluorene and carbon tetrachloride. Naunyn Schmiedebergs Arch Pharmacol 1983; 322: 310-8.
251. Groothuis GMM, Meijer DKF, Hardonk MJ. Morphological studies on selective acinar liver damage by N-hydroxy2-acetylaminofluorene and carbon tetrachloride. Naunyn Schmiedebergs Arch Pharmacol 1983; 322: 298-309.
252. Chen EH, Gumucio JJ, Ho NH, Gumucio DL. Hepatocytes of zones 1 and 3 conjugate sulfobromophthalein with glutathione. Hepatology 1984; 4: 467-76.